Data / Form D filings / Vero Biotech Inc.
Vero Biotech Inc.: Form D filings
Vero Biotech Inc., a pharmaceuticals company in Atlanta, GA, filed 7 Form D notices with the SEC between 2009 and 2021. The latest, on December 22, 2021, reports $27.3 million sold of a $99.5 million offering to 5 investors.
Find out what Vero Biotech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 387 TECHNOLOGY CIR. NW, SUITE 125, Atlanta, GA, 30313
- Phone
- (678) 862-7729
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1359620
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | New notice | $99,530,958 | $27,265,773 | $72,265,185 | 5 | Dec 8, 2021 | sec.gov |
| Sep 29, 2017 | New notice | $35,100,000 | $29,941,000 | $5,159,000 | 31 | Sep 1, 2017 | sec.gov |
| Oct 18, 2013 | Amendment | $17,000,000 | $14,738,606 | $2,261,394 | 41 | Sep 20, 2013 | sec.gov |
| Oct 3, 2013 | New notice | $14,570,606 | $14,570,606 | $0 | 39 | Sep 20, 2013 | sec.gov |
| Dec 29, 2011 | New notice | $10,500,000 | $7,990,819 | $2,509,181 | 21 | Feb 17, 2011 | sec.gov |
| Sep 14, 2009 | New notice | $3,500,000 | $2,136,030 | $1,363,970 | 18 | Sep 2, 2009 | sec.gov |
| Sep 14, 2009 | New notice | $3,000,000 | $2,136,030 | $863,970 | 18 | Sep 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Todd Brady | Director | |
| Daniel Salazar | Director | |
| Thiago V. Tavares | Director | |
| Shasha V. Zou | Executive Officer | |
| Eric V. Bednarski | Director | |
| Brent V. Furse | Executive Officer, Director | |
| Roberto V. Cohen | Executive Officer |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Dec 20, 2021 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vero Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.